Key result
Unfavorable cardiometabolic phenotype in obese HF linked to worse exercise capacity and quality of life.
Why the study?
The functional manifestations of an unfavorable cardiometabolic phenotype in patients with chronic heart failure and obesity, specifically regarding exercise tolerance and quality of life, required assessment.
Does an unfavorable cardiometabolic phenotype impair exercise tolerance and quality of life in patients with chronic heart failure and obesity?
Cross-Sectional
Does an unfavorable cardiometabolic phenotype impair exercise tolerance and quality of life in patients with chronic heart failure and obesity?
An unfavorable cardiometabolic phenotype in obese patients with chronic heart failure is linked to chronotropic incompetence, impaired aerobic capacity, and reduced quality of life, supporting targeted cardiometabolic rehabilitation.
Answers are grounded in this paper and cite their sources.
May indicate worse functional status in obese HF with unfavorable phenotype; leaves open prospective confirmation before guiding management.
Objective. To assess the functional manifestations of an unfavorable cardiometabolic phenotype in patients with chronic heart failure and obesity based on an analysis of exercise tolerance and quality-of-life indicators. Materials and methods. A cross-sectional comparative study included patients with obesity and chronic heart failure, as well as individuals with obesity without clinical signs of heart failure. To assess the severity of cardiometabolic disorders, the examined patients were stratified by the presence of an unfavorable metabolic phenotype. Functional status was studied using a treadmill test with analysis of exercise duration, workload achieved, estimated oxygen consumption (VO₂), chronotropic index, heart rate increment, and features of the hemodynamic response to exercise. Quality of life was assessed with the Minnesota Living with Heart Failure Questionnaire (MLHFQ) and the SF-36. Results. The formation of an unfavorable cardiometabolic phenotype was accompanied by a significant reduction in the functional reserve of the cardiovascular system. The examined patients showed lower treadmill test duration, workload achieved, oxygen consumption, chronotropic index, and heart rate increment, together with an enhanced pressor response to exercise. According to the MLHFQ, more pronounced limitations of physical activity, increased emotional distress, and worse integral quality-of-life scores were found. According to the SF-36, physical functioning, vitality, and general health scores were reduced. Conclusion. An unfavorable cardiometabolic phenotype in patients with chronic heart failure and obesity is associated with reduced aerobic working capacity, the development of chronotropic incompetence, impaired adaptive mechanisms of the cardiovascular system, and worse quality of life. The results obtained justify the introduction of cardiometabolic rehabilitation programs aimed at increasing functional reserve, optimizing the hemodynamic response to exercise, and improving the clinical status of patients.
No takes yet. Share an insight, caveat, or question.
Tashkenbaeva et al. (2026) conducted a cross-sectional in Chronic heart failure and obesity. Unfavorable cardiometabolic phenotype vs. Individuals with obesity without clinical signs of heart failure or without an unfavorable metabolic phenotype was evaluated on Exercise tolerance (treadmill test duration, workload achieved, estimated VO2, chronotropic index, heart rate increment, hemodynamic response) and quality of life (MLHFQ and SF-36). An unfavorable cardiometabolic phenotype in patients with chronic heart failure and obesity was associated with reduced exercise duration, VO₂, chronotropic index, and quality of life.
Synapse has enriched 10 related papers. Consider them for comparative context: